Advanced cell assays, such as those that model disease states and are suitable for screening therapeutic agents, are often laborious to develop, involving many stages, and may only be ready to test after relatively long timeframes. The culture may require patient-derived or induced pluripotent stem cells (iPSC) and may then undergo manipulations, such as differentiation, activation, or genetic modulation via techniques such as CRISPR/Cas9. Further complexities in the cellular organization may also be required, for example, the use of co/multi-cultures or the formation of 3D structures.
This whitepaper illustrates the importance of live-cell monitoring for complex, recurrent workflows and, with the ability to perform multiparametric imaging techniques in a non-perturbing manner, its relevance to the fields of immunology, oncology, and neuroscience are highlighted.
There is focus on:
Find out how to ensure confidence in monitoring your cell assays.
Interested in learning more? Complete the form below to download the FREE white paper!